European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging
Title	European Journal of Nuclear Medicine and Molecular Imaging
Abbreviation	Eur J Nucl Med Mol Imaging
Discipline	Nuclear medicine; Molecular imaging
Editor	Various
Publisher	Springer Science+Business Media
History	1976–present
Frequency	Monthly
Impact	See text
Issn	1619-7089

Contents

European Journal of Nuclear Medicine and Molecular Imaging

The European Journal of Nuclear Medicine and Molecular Imaging is a peer-reviewed monthly journal founded in 1976 that serves the international communities of European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, World Health Organization, International Atomic Energy Agency, and related organizations, while engaging researchers from institutions such as University College London, Karolinska Institute, Harvard Medical School, Mayo Clinic, and University of Cambridge. The journal publishes original research, reviews, guidelines, and editorials that intersect with applied practice at centers like Gustave Roussy, Institut Curie, Dana–Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, and Johns Hopkins Hospital. It frequently features work connected to consortia and initiatives involving European Commission, National Institutes of Health, Wellcome Trust, European Molecular Biology Laboratory, and Horizon 2020 projects.

History

The journal was established in 1976 amid developments led by figures affiliated with Raymond L. Adams-era institutions and committees such as European Association of Nuclear Medicine and early panels of the International Atomic Energy Agency, paralleling advances at Massachusetts General Hospital, Mayo Clinic, Stanford University School of Medicine, University of Pennsylvania, and Karolinska Institute. Over decades it reflected methodological shifts influenced by work at CERN, Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, and clinical programs at Hôpital Necker–Enfants Malades and Charité – Universitätsmedizin Berlin. Milestones included special issues coinciding with conferences like European Congress of Radiology, SNMMI Annual Meeting, and landmark guidelines developed in collaboration with European Society for Medical Oncology, European Organisation for Research and Treatment of Cancer, and regulatory discussions involving European Medicines Agency.

The journal covers clinical and translational research linking nuclear medicine topics studied at Karolinska Institute, Imperial College London, University of Oxford, McGill University, and Yale School of Medicine with molecular imaging approaches from laboratories at Max Planck Society, Wellcome Trust Sanger Institute, European Molecular Biology Laboratory, Cold Spring Harbor Laboratory, and Institute Pasteur. Manuscripts often address radiopharmaceutical development tied to companies and centers like Novartis, GE Healthcare, Siemens Healthineers, Roche, and Bayer, and include comparative studies relevant to practice at Cleveland Clinic, UCLA Medical Center, Mount Sinai Health System, and John Radcliffe Hospital. Topics include PET, SPECT, hybrid PET/CT and PET/MRI modalities applied to oncology, cardiology, neurology, and inflammation with cross-references to guidelines from European Society of Cardiology, European Academy of Neurology, and trials registered with European Clinical Trials Database.

Editorial leadership has involved editors and editorial boards drawn from institutions such as University of Oxford, Karolinska Institute, University of Milan, University of Turin, and Université Paris Cité, with governance reflecting connections to societies like European Association of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging, and advisory input from experts at Harvard Medical School and Johns Hopkins University. The publisher, Springer Science+Business Media, coordinates production and distribution alongside publishing partners and indexing collaborations with entities such as Clarivate Analytics, Elsevier, and PubMed Central infrastructures maintained by National Library of Medicine.

The journal is abstracted and indexed in major services tied to institutions and companies including Clarivate Analytics's Science Citation Index, Scopus operated by Elsevier, MEDLINE via National Library of Medicine, and databases used by universities like University of Cambridge, Harvard University, University of Tokyo, and Peking University. It is discoverable through library systems and aggregators associated with WorldCat, CrossRef, Google Scholar managed by Google, and research infrastructures supported by OpenAIRE and Europeana.

The journal's impact has been discussed in contexts involving metrics from Clarivate Analytics, debates at meetings of European Association of Nuclear Medicine, and comparisons published by analysts at Elsevier and SCImago Institutions Rankings. Influential editorials and citation patterns link to landmark work originating at Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Karolinska Institute, Imperial College London, and Stanford University School of Medicine, and are cited in guidelines from European Society for Medical Oncology and position papers from World Health Organization collaborations. The title has been both lauded for translational breadth by committees involving European Commission reviewers and critiqued in methodological debates appearing at SNMMI Annual Meeting.

Notable contributions include multicenter trials and methodology papers authored by groups associated with Karolinska Institute, Johns Hopkins University, Mayo Clinic, Memorial Sloan Kettering Cancer Center, and Utrecht University that influenced practice guidelines similar to those developed by European Society of Cardiology and European Academy of Neurology. Special issues have coincided with congresses such as European Congress of Radiology, thematic collections honoring investigators from Institut Curie and Gustave Roussy, and reviews linked to initiatives by European Molecular Biology Laboratory and funding calls from Horizon 2020.

The journal is published monthly by Springer Science+Business Media and operates a hybrid publication model reflecting policies aligned with funders including Wellcome Trust, National Institutes of Health, European Commission, European Research Council, and institutional repositories at University of Oxford and Karolinska Institute. Authors affiliated with institutions like Imperial College London, Harvard Medical School, University of Cambridge, and University of Toronto may choose open access options or traditional subscription routes, with archiving coordinated through infrastructures such as PubMed Central and national libraries including British Library.

Category:Academic journals